Evidence map›Paper›PMID 41051760›Full record

ArticleJAMA neurology2025

Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS).

Helen Kim, Jeffrey Nelson, Charles E McCulloch, Christopher Hess, Steven W Hetts, Kelly Flemming, Giuseppe S Lanzino, Päivi Koroknay-Pál, Elias Oulasvirta, Aki Laakso and 9 more

Abstract readMulticenter Study
In one paragraph

Article in JAMA neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Perioperative outcomes and risk stratification following pediatric arteriovenous malformation resection: an ACS NSQIP-P database analysis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Helen KimCenter for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco.
Jeffrey NelsonCenter for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco.
Charles E McCullochDepartment of Epidemiology and Biostatistics, University of California, San Francisco.
Christopher HessDepartment of Radiology and Biomedical Imaging, University of California, San Francisco.
Steven W HettsDepartment of Radiology and Biomedical Imaging, University of California, San Francisco.
Kelly FlemmingDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Giuseppe S LanzinoDepartment of Neurosurgery, Mayo Clinic, Rochester, Minnesota.
Päivi Koroknay-PálDepartment of Neurosurgery, Helsinki University Hospital, Helsinki, Finland.
Elias OulasvirtaDepartment of Neurosurgery, Helsinki University Hospital, Helsinki, Finland.
Aki LaaksoDepartment of Neurosurgery, Helsinki University Hospital, Helsinki, Finland.
Michael T LawtonDepartment of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona.
Jay P MohrDepartment of Neurology, Columbia University, New York, New York.
Michael K MorganMacquarie University, Sydney, New South Wales, Australia.
Nicole MoayeriSanta Barbara Cottage Hospital, Santa Barbara, California.
Jonathan G ZaroffKaiser Permanente San Francisco Medical Center, San Francisco, California.
Marco A StefaniDepartment of Neurology and Neurosurgery, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
Xiaolin ChenBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yuanli ZhaoBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Rustam Al-Shahi SalmanInstitute for Neuroscience and Cardiovascular Research, The University of Edinburgh, Edinburgh, Great Britain.

Funding

Long-term outcomes in unruptured brain arteriovenous malformation patientsR01NS099268 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KIM, HELEN · 2017 to 2021
$3.1M
NINDS NIH HHS R01 NS099268
6 · The paper itself

Abstract

Importance: Annual rates of first intracranial hemorrhage (ICH) from unruptured brain arteriovenous malformations (AVMs) are often quoted as 2% to 4% in clinical practice. Precise estimates and risk factors are unavailable to inform treatment decisions. Objective: To provide estimates of rates and risk factors for first ICH in a large cohort study of unruptured brain AVMs. Design, Setting, and Participants: The Multicenter Arteriovenous Malformation Research Study (MARS) included data from 9 cohorts, each contributing 100 or more unruptured brain AVMs. The study was conducted from 2017 to 2023 with retrospective and prospective data collection for existing cohorts and/or new recruitment. This was an international study (2 population-based and 7 referral-based cohorts) that included participants diagnosed with an unruptured brain AVM. Exposures: Demographic, clinical, and angiographic characteristics. Main Outcome and Measure: The primary outcome was time to first ICH after diagnosis of unruptured brain AVM. Data were collected using standardized definitions; missing data were imputed. Cox regression analysis was performed, censoring at first brain AVM treatment, death, or last visit, and allowing baseline hazards to vary by cohort. Results: A total of 3225 individuals were eligible for participation in this study. After 195 exclusions, 3030 participants (median [IQR] age, 38 [25-50] years; 1524 female [50.3%]) were included. Among 2989 participants with unruptured brain AVMs, 1333 (45%) presented with seizure. The median (IQR) maximal brain AVM diameter was 3.1 (2.2-4.4) cm, 248 of 2466 AVMs (10%) had exclusively deep venous drainage, 297 of 2690 (11%) were in supratentorial deep or cerebellar locations, and 457 of 2440 (19%) had associated arterial aneurysms. First ICH occurred in 159 participants over 11 339 person-years of follow-up for an ICH rate of 1.40 (95% CI, 1.20-1.64) per 100 person-years. Significant independent risk factors included (1) increasing age category at diagnosis (hazard ratio [HR], 0.87; 95% CI, 0.53-1.41 for those aged 20 to 39 years; HR, 1.23; 95% CI, 0.74-2.04 for those aged 40 to 59 years; and HR, 2.01; 95% CI, 1.14-3.57 for those aged 60 years vs younger than 20 years; P = .008), (2) presence of associated aneurysms (HR, 1.66; 95% CI, 1.06-2.59; P = .03), and (3) cerebellar or supratentorial deep location (HR, 1.87; 95% CI, 1.16-3.00; P = .01). Conclusions and Relevance: The annual ICH rate from unruptured brain AVM was lower than that commonly cited in clinical practice. Increasing age, associated arterial aneurysms, and cerebellar or supratentorial deep brain AVM location were associated with risk of first ICH. These results may be used to counsel patients about the natural history of unruptured brain AVMs.

Indexed as

Intracranial Arteriovenous MalformationsIntracranial HemorrhagesAdultAgedCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsYoung Adult

Identifiers

PMID41051760
PMCPMC12501859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.